Jing Zhou

Glucagon-like peptide 1 receptor agonists in cardiovascular-kidney-metabolic syndrome: a review

With the rising global prevalence of obesity and type 2 diabetes, metabolic disorders have become major drivers of cardiovascular morbidity and mortality worldwide. Cardiovascular-kidney-metabolic (CKM) syndrome encompasses obesity, type 2 diabetes mellitus (T2DM), chronic kidney...